Clinical Monitoring and Safety
All other glucose-lowering therapies are stopped on the day the diet begins. GLP-1 receptor agonists and SGLT2 inhibitors are stopped one week before the low-energy diet begins. Common adverse events in low-energy diet trials include const…
1 sources - 6 claims
All other glucose-lowering therapies are stopped on the day the diet begins. GLP-1 receptor agonists and SGLT2 inhibitors are stopped one week before the low-energy diet begins. Common adverse events in low-energy diet trials include constipation, headache, dizziness, fatigue, and thirst.